Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-039967
Filing Date
2025-08-12
Accepted
2025-08-12 17:24:42
Documents
78
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zvra-20250630.htm   iXBRL 10-Q 1237787
2 EX-31.1 zvra-20250630xex311.htm EX-31.1 10000
3 EX-31.2 zvra-20250630xex312.htm EX-31.2 10007
4 EX-32.1 zvra-20250630xex321.htm EX-32.1 5645
5 EX-32.2 zvra-20250630xex322.htm EX-32.2 5658
  Complete submission text file 0001628280-25-039967.txt   7151370

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zvra-20250630.xsd EX-101.SCH 54519
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zvra-20250630_cal.xml EX-101.CAL 89434
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zvra-20250630_def.xml EX-101.DEF 186445
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zvra-20250630_lab.xml EX-101.LAB 654908
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zvra-20250630_pre.xml EX-101.PRE 439420
81 EXTRACTED XBRL INSTANCE DOCUMENT zvra-20250630_htm.xml XML 1006083
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 251208056
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)